{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T20:06:23Z","timestamp":1775160383428,"version":"3.50.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,19]],"date-time":"2025-01-19T00:00:00Z","timestamp":1737244800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,1,19]],"date-time":"2025-01-19T00:00:00Z","timestamp":1737244800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000090","name":"Congressionally Directed Medical Research Programs","doi-asserted-by":"publisher","award":["W81XWH-18-1-0709"],"award-info":[{"award-number":["W81XWH-18-1-0709"]}],"id":[{"id":"10.13039\/100000090","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01 HL090957"],"award-info":[{"award-number":["R01 HL090957"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01 HL146158"],"award-info":[{"award-number":["R01 HL146158"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01 HL153500"],"award-info":[{"award-number":["R01 HL153500"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["N01-HV-68161"],"award-info":[{"award-number":["N01-HV-68161"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["N01-HV-68162"],"award-info":[{"award-number":["N01-HV-68162"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["N01-HV-68163"],"award-info":[{"award-number":["N01-HV-68163"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["N01-HV-68164"],"award-info":[{"award-number":["N01-HV-68164"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["U0164829"],"award-info":[{"award-number":["U0164829"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["U01 HL649141"],"award-info":[{"award-number":["U01 HL649141"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["U01 HL649241"],"award-info":[{"award-number":["U01 HL649241"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["1R03AG032631"],"award-info":[{"award-number":["1R03AG032631"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000097","name":"National Center for Research Resources","doi-asserted-by":"publisher","award":["MO1-RR0042"],"award-info":[{"award-number":["MO1-RR0042"]}],"id":[{"id":"10.13039\/100000097","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1TR000124"],"award-info":[{"award-number":["UL1TR000124"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["1R01AI164504"],"award-info":[{"award-number":["1R01AI164504"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Systemic lupus erythematosus (SLE) patients are 90% women and over three times more likely to die of cardiovascular disease than women in the general population. Chest pain with no obstructive cardiac disease is associated with coronary microvascular disease (CMD), where narrowing of the small blood vessels can lead to ischemia, and frequently reported by SLE patients. Using whole blood RNA samples, we asked whether gene signatures discriminate SLE patients with coronary microvascular dysfunction (CMD) on cardiac MRI (n\u2009=\u20094) from those without (n\u2009=\u20097) and whether any signaling pathway is linked to the underlying pathobiology of SLE CMD. RNA-seq analysis revealed 143 differentially expressed (DE) genes between the SLE and healthy control (HC) groups, with virus defense and interferon (IFN) signaling being the key pathways identified as enriched in SLE as expected. We next conducted a comparative analysis of genes differentially expressed in SLE\u2013CMD and SLE\u2013non-CMD relative to HC samples. Our analysis highlighted differences in IFN signaling, RNA sensing and ADP-ribosylation pathways between SLE\u2013CMD and SLE\u2013non-CMD. This is the first study to investigate possible gene signatures associating with CMD in SLE, and our data strongly suggests that distinct molecular mechanisms underly vascular changes in CMD and non-CMD involvement in SLE.<\/jats:p>","DOI":"10.1038\/s41598-024-82190-4","type":"journal-article","created":{"date-parts":[[2025,1,19]],"date-time":"2025-01-19T16:21:52Z","timestamp":1737303712000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Alterations in genes associated with cytosolic RNA sensing in whole blood are associated with coronary microvascular disease in SLE"],"prefix":"10.1038","volume":"15","author":[{"given":"Lihong","family":"Huo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arati","family":"Naveen Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gantsetseg","family":"Tumurkhuu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moumita","family":"Bose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel S.","family":"Berman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel J.","family":"Wallace","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janet","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariko","family":"Ishimori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. Noel","family":"Bairey Merz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline","family":"Jefferies","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,1,19]]},"reference":[{"issue":"13","key":"82190_CR1","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1016\/j.jacc.2021.07.042","volume":"78","author":"MG Del Buono","year":"2021","unstructured":"Del Buono, M. G. et al. Coronary microvascular dysfunction across the spectrum of cardiovascular diseases: JACC state-of-the-art review. J. Am. Coll. Cardiol. 78(13), 1352\u20131371 (2021).","journal-title":"J. Am. Coll. Cardiol."},{"issue":"21","key":"82190_CR2","doi-asserted-by":"publisher","first-page":"2625","DOI":"10.1016\/j.jacc.2018.09.042","volume":"72","author":"VR Taqueti","year":"2018","unstructured":"Taqueti, V. R. & Di Carli, M. F. Coronary microvascular disease pathogenic mechanisms and therapeutic options: JACC state-of-the-art review. J. Am. Coll. Cardiol. 72(21), 2625\u20132641 (2018).","journal-title":"J. Am. Coll. Cardiol."},{"issue":"3","key":"82190_CR3","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.115.003064","volume":"5","author":"ND Mygind","year":"2016","unstructured":"Mygind, N. D. et al. Coronary microvascular function and cardiovascular risk factors in women with angina pectoris and no obstructive coronary artery disease: The iPOWER study. J. Am. Heart Assoc. 5(3), e003064 (2016).","journal-title":"J. Am. Heart Assoc."},{"key":"82190_CR4","doi-asserted-by":"publisher","DOI":"10.15420\/ecr.2020.47","volume":"16","author":"S Godo","year":"2021","unstructured":"Godo, S. et al. Role of Inflammation in coronary epicardial and microvascular dysfunction. Eur. Cardiol. 16, e13 (2021).","journal-title":"Eur. Cardiol."},{"issue":"4","key":"82190_CR5","doi-asserted-by":"publisher","first-page":"497","DOI":"10.2217\/fca-2016-0012","volume":"12","author":"OY Hung","year":"2016","unstructured":"Hung, O. Y. et al. Novel biomarkers of coronary microvascular disease. Future Cardiol. 12(4), 497\u2013509 (2016).","journal-title":"Future Cardiol."},{"key":"82190_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.867155","volume":"9","author":"AS Manchanda","year":"2022","unstructured":"Manchanda, A. S. et al. Coronary microvascular dysfunction in patients with systemic lupus erythematosus and chest pain. Front. Cardiovasc. Med. 9, 867155 (2022).","journal-title":"Front. Cardiovasc. Med."},{"issue":"4","key":"82190_CR7","doi-asserted-by":"publisher","first-page":"197","DOI":"10.26502\/jrci.2809088","volume":"6","author":"AM Hagiwara","year":"2023","unstructured":"Hagiwara, A. M. et al. Reduced left ventricular function on cardiac MRI in SLE patients correlates with measures of SLE disease activity and inflammation. J. Radiol. Clin. Imaging 6(4), 197\u2013207 (2023).","journal-title":"J. Radiol. Clin. Imaging"},{"key":"82190_CR8","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1038\/s42003-019-0382-x","volume":"2","author":"MD Catalina","year":"2019","unstructured":"Catalina, M. D. et al. Gene expression analysis delineates the potential roles of multiple interferons in systemic lupus erythematosus. Commun. Biol. 2, 140 (2019).","journal-title":"Commun. Biol."},{"issue":"4","key":"82190_CR9","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1002\/art.30187","volume":"63","author":"CE Weckerle","year":"2011","unstructured":"Weckerle, C. E. et al. Network analysis of associations between serum interferon-alpha activity, autoantibodies, and clinical features in systemic lupus erythematosus. Arthritis Rheum 63(4), 1044\u20131053 (2011).","journal-title":"Arthritis Rheum"},{"issue":"12","key":"82190_CR10","doi-asserted-by":"publisher","first-page":"5459","DOI":"10.4049\/jimmunol.1002795","volume":"192","author":"MK Crow","year":"2014","unstructured":"Crow, M. K. Type I interferon in the pathogenesis of lupus. J. Immunol. 192(12), 5459\u20135468 (2014).","journal-title":"J. Immunol."},{"issue":"5","key":"82190_CR11","doi-asserted-by":"publisher","first-page":"2610","DOI":"10.1073\/pnas.0337679100","volume":"100","author":"EC Baechler","year":"2003","unstructured":"Baechler, E. C. et al. Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc. Natl. Acad. Sci. U. S. A. 100(5), 2610\u20132615 (2003).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"82190_CR12","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.bbrc.2012.02.116","volume":"420","author":"T Asdonk","year":"2012","unstructured":"Asdonk, T. et al. Endothelial RIG-I activation impairs endothelial function. Biochem. Biophys. Res. Commun. 420(1), 66\u201371 (2012).","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"82190_CR13","doi-asserted-by":"publisher","first-page":"2681","DOI":"10.1038\/s41467-021-23003-4","volume":"12","author":"J Xing","year":"2021","unstructured":"Xing, J. et al. Identification of poly(ADP-ribose) polymerase 9 (PARP9) as a noncanonical sensor for RNA virus in dendritic cells. Nat. Commun. 12(1), 2681 (2021).","journal-title":"Nat. Commun."},{"issue":"7","key":"82190_CR14","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.4049\/jimmunol.1701117","volume":"200","author":"G Caprara","year":"2018","unstructured":"Caprara, G. et al. PARP14 controls the nuclear accumulation of a subset of Type I IFN-inducible proteins. J. Immunol. 200(7), 2439\u20132454 (2018).","journal-title":"J. Immunol."},{"issue":"5","key":"82190_CR15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1007756","volume":"15","author":"ME Grunewald","year":"2019","unstructured":"Grunewald, M. E. et al. The coronavirus macrodomain is required to prevent PARP-mediated inhibition of virus replication and enhancement of IFN expression. PLoS Pathog. 15(5), e1007756 (2019).","journal-title":"PLoS Pathog."},{"issue":"4","key":"82190_CR16","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1093\/cvr\/cvy254","volume":"115","author":"K Matsumoto","year":"2019","unstructured":"Matsumoto, K. et al. Blockade of NKG2D\/NKG2D ligand interaction attenuated cardiac remodelling after myocardial infarction. Cardiovasc. Res. 115(4), 765\u2013775 (2019).","journal-title":"Cardiovasc. Res."},{"issue":"11","key":"82190_CR17","doi-asserted-by":"publisher","first-page":"4884","DOI":"10.1172\/JCI120859","volume":"128","author":"JS Tilstra","year":"2018","unstructured":"Tilstra, J. S. et al. Kidney-infiltrating T cells in murine lupus nephritis are metabolically and functionally exhausted. J. Clin. Invest. 128(11), 4884\u20134897 (2018).","journal-title":"J. Clin. Invest."},{"issue":"26","key":"82190_CR18","doi-asserted-by":"publisher","first-page":"2590","DOI":"10.1093\/eurheartj\/ehaa857","volume":"42","author":"S Masi","year":"2020","unstructured":"Masi, S. et al. Assessment and pathophysiology of microvascular disease: recent progress and clinical implications. Eur. Heart J. 42(26), 2590\u20132604 (2020).","journal-title":"Eur. Heart J."},{"issue":"19","key":"82190_CR19","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.1161\/CIRCULATIONAHA.110.956839","volume":"123","author":"DE Handy","year":"2011","unstructured":"Handy, D. E., Castro, R. & Loscalzo, J. Epigenetic modifications: basic mechanisms and role in cardiovascular disease. Circulation 123(19), 2145\u20132156 (2011).","journal-title":"Circulation"},{"issue":"4\u20135","key":"82190_CR20","doi-asserted-by":"publisher","DOI":"10.1111\/micc.12757","volume":"29","author":"M Caliskan","year":"2022","unstructured":"Caliskan, M. et al. Coronary microvascular dysfunction is common in patients hospitalized with COVID-19 infection. Microcirculation 29(4\u20135), e12757 (2022).","journal-title":"Microcirculation"},{"issue":"8_Supplement","key":"82190_CR21","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1016\/S0735-1097(23)01913-7","volume":"81","author":"I Ahmed Ahmed","year":"2023","unstructured":"Ahmed Ahmed, I. et al. Coronary microvascular dysfunction in patients with prior covid-19 infection and persistent symptoms: Impact of duration since the infection. J. Am. Coll. Cardiol. 81(8_Supplement), 1469\u20131469 (2023).","journal-title":"J. Am. Coll. Cardiol."},{"issue":"3","key":"82190_CR22","first-page":"100141","volume":"2","author":"T Wu","year":"2021","unstructured":"Wu, T. et al. clusterProfiler 4.0: A universal enrichment tool for interpreting omics data. Innovation (Camb) 2(3), 100141 (2021).","journal-title":"Innovation (Camb)"},{"key":"82190_CR23","doi-asserted-by":"publisher","first-page":"858","DOI":"10.3389\/fgene.2019.00858","volume":"10","author":"E Ulgen","year":"2019","unstructured":"Ulgen, E., Ozisik, O. & Sezerman, O. U. pathfindR: An R package for comprehensive identification of enriched pathways in omics data through active subnetworks. Front. Genet. 10, 858 (2019).","journal-title":"Front. Genet."},{"key":"82190_CR24","doi-asserted-by":"crossref","unstructured":"Baksh, S.S., et al., Rig1 receptor plays a critical role in cardiac reprogramming via YY1 signaling. Am J Physiol Cell Physiol. 324(4), C843-C855 (2023).","DOI":"10.1152\/ajpcell.00402.2022"},{"key":"82190_CR25","doi-asserted-by":"crossref","unstructured":"Oduro, P.K., et al., The cGAS-STING signaling in cardiovascular and metabolic diseases: Future novel target option for pharmacotherapy. Acta Pharm Sin B. 12(1), 50-75 (2022).","DOI":"10.1016\/j.apsb.2021.05.011"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-82190-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-82190-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-82190-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,19]],"date-time":"2025-01-19T16:21:55Z","timestamp":1737303715000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-82190-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,19]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["82190"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-82190-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.02.19.580713","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-4171759\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,19]]},"assertion":[{"value":"26 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The experiments were approved by the institutional review board at Cedars-Sinai Medical Center, which oversees the approval of experiments, specifically in the realm of medical ethics. We confirm that all experiments were conducted in accordance with relevant guidelines and regulations, including the Principles of Human Experimentation Ethics and Good Clinical Practice.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"2457"}}